Cart is empty While Immune Checkpoint Inhibitor (ICI) immunotherapy drugs have transformed the treatment of many cancers, some lung cancer patients experience hyperprogression—a paradoxical rapid acceleration of tumor growth—after the treatment begins.
While Immune Checkpoint Inhibitor (ICI) immunotherapy drugs have transformed the treatment of many cancers, some lung cancer patients experience hyperprogression—a paradoxical rapid acceleration of tumor growth—after the treatment begins.
Leave A Comment